Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexei Kharitonenkov

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Endocrinology|April 30, 2015
Central Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male MiceNicholas Douris, Darko M Stevanovic, Ffolliott M Fisher, et al.
Endocrinology|March 17, 2015
Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21Julia M Assini, Erin E Mulvihill, Amy C Burke, et al.
Molecular Metabolism|October 1, 2016
Fibroblast activation protein (FAP) as a novel metabolic targetMiguel Angel Sánchez-Garrido, Kirk M Habegger, Christoffer Clemmensen, et al.
JCI Insight|January 7, 2021
Glucagon receptor signaling regulates weight loss via central KLB receptor complexesShelly R Nason, Jessica Antipenko, Natalie Presedo, et al.
Cell Metabolism|May 14, 2013
An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in miceWilliam L Holland, Andrew C Adams, Joseph T Brozinick, et al.
Plos One|March 29, 2013
Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319Alexei Kharitonenkov, John M Beals, Radmila Micanovic, et al.
The Journal of Clinical Investigation|May 20, 2005
FGF-21 as a novel metabolic regulatorAlexei Kharitonenkov, Tatiyana L Shiyanova, Anja Koester, et al.
The Journal of Clinical Investigation|November 29, 2012
Circulating αKlotho influences phosphate handling by controlling FGF23 productionRosamund C Smith, Linda M O'Bryan, Emily G Farrow, et al.
Diabetes|January 12, 2013
Fibroblast growth factor 21 mediates specific glucagon actionsKirk M Habegger, Kerstin Stemmer, Christine Cheng, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Endocrinology|April 30, 2015
Central Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male MiceNicholas Douris, Darko M Stevanovic, Ffolliott M Fisher, et al.
Endocrinology|March 17, 2015
Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21Julia M Assini, Erin E Mulvihill, Amy C Burke, et al.
Molecular Metabolism|October 1, 2016
Fibroblast activation protein (FAP) as a novel metabolic targetMiguel Angel Sánchez-Garrido, Kirk M Habegger, Christoffer Clemmensen, et al.
JCI Insight|January 7, 2021
Glucagon receptor signaling regulates weight loss via central KLB receptor complexesShelly R Nason, Jessica Antipenko, Natalie Presedo, et al.
Cell Metabolism|May 14, 2013
An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in miceWilliam L Holland, Andrew C Adams, Joseph T Brozinick, et al.
Plos One|March 29, 2013
Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319Alexei Kharitonenkov, John M Beals, Radmila Micanovic, et al.
The Journal of Clinical Investigation|May 20, 2005
FGF-21 as a novel metabolic regulatorAlexei Kharitonenkov, Tatiyana L Shiyanova, Anja Koester, et al.
The Journal of Clinical Investigation|November 29, 2012
Circulating αKlotho influences phosphate handling by controlling FGF23 productionRosamund C Smith, Linda M O'Bryan, Emily G Farrow, et al.
Diabetes|January 12, 2013
Fibroblast growth factor 21 mediates specific glucagon actionsKirk M Habegger, Kerstin Stemmer, Christine Cheng, et al.
Pageof 7